Revision of Previously Issued Financial Statements for Correction of Immaterial Errors (Details 1) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Research and development | $ 3,852 | $ 80,983 | $ 16,414 | $ 204,704 | ||
| Total operating expenses | 166,850 | 268,356 | 432,431 | 1,765,042 | ||
| Loss from operations | (166,850) | (268,356) | (432,431) | (1,765,042) | ||
| Net loss | $ (284,140) | $ (315,842) | $ (315,187) | $ (1,539,129) | $ (599,982) | $ (1,854,316) |
| Basic and diluted net loss per common share | $ (0.00) | $ (0.00) | $ (0.00) | $ (0.01) | ||
| As Previously Reported [Member] | ||||||
| Research and development | $ 197,234 | |||||
| Total operating expenses | 1,757,572 | |||||
| Loss from operations | (1,757,572) | |||||
| Net loss | $ (315,187) | (1,531,659) | $ (1,846,846) | |||
| Basic and diluted net loss per common share | $ (0.01) | |||||
| Adjustment [Member] | ||||||
| Research and development | $ 7,470 | |||||
| Total operating expenses | 7,470 | |||||
| Loss from operations | (7,470) | |||||
| Net loss | 0 | (7,470) | $ (7,470) | |||
| Basic and diluted net loss per common share | $ 0 | |||||
| As Restated [Member] | ||||||
| Research and development | $ 204,704 | |||||
| Total operating expenses | 1,765,042 | |||||
| Loss from operations | (1,765,042) | |||||
| Net loss | $ (315,187) | $ (1,539,129) | $ (1,854,316) | |||
| Basic and diluted net loss per common share | $ (0.01) | |||||
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|